Cipla500087Pharmaceuticals
Cipla's US revenue came in at $172 million, well below earlier estimates of around $240 million, with full launches guidance of four to five for the year
By ScoutQuest · · 1 min read
- US revenue this quarter
- 172 million dollars
- Earlier US revenue estimate
- 240 million dollars
Heard on business television between 13:35:14 - 13:38:14 IST.
- Analyst noted Cipla's US revenue was $172 million versus earlier estimate of around $240 million, calling it much lower than expected.
- Company had guided for four to five major launches this year, with two to three already completed.
- Analyst said margins remain a positive, but topline growth has been disappointing given high US exposure.
- Expected continued pressure on US revenue growth in coming quarters due to fewer incremental launches.
Watch at source
behind live
- 1Open on YouTube
- 2Drag the seek bar left
- 3Watch this moment
Also from Cipla
Cipla reported modest Q2 numbers but maintained its US revenue and EBITDA margin guidance, prompting mixed brokerage reactions
28 Oct 2026
Cipla posts audio recording of Q2/H1 FY27 earnings conference call on its website
27 Oct 2026
Cipla's Q2 results were largely in line with estimates, with a dip in profit and muted US sales due to supply issues
27 Oct 2026
Source: Live TV News Channel · 27 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.